Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 209,357 | 187,118 | 141,838 | 94,419 | 57,365 |
| Cost of Goods | 41,093 | 35,181 | 25,532 | 16,888 | 12,470 |
| Gross Profit | 168,264 | 151,937 | 116,306 | 77,531 | 44,895 |
| Operating Expenses | 224,045 | 203,546 | 151,682 | 94,929 | 44,510 |
| Operating Income | -55,688 | -51,428 | -34,844 | -16,510 | 855 |
| Interest Expense | 5,256 | 5,167 | 4,398 | 4,060 | 2,777 |
| Other Income | 5,201 | 7,068 | -3,573 | 18 | -1,746 |
| Pre-tax Income | -55,743 | -49,527 | -42,815 | -20,552 | -3,668 |
| Net Income Continuous | -55,743 | -49,527 | -42,815 | -20,552 | -3,668 |
| Net Income | $-55,743 | $-49,527 | $-42,815 | $-20,552 | $-3,668 |
| EPS Basic Total Ops | -0.90 | -0.81 | -0.77 | -0.43 | -0.12 |
| EPS Basic Continuous Ops | -0.90 | -0.81 | -0.77 | -0.42 | -0.10 |
| EPS Diluted Total Ops | -0.90 | -0.81 | -0.77 | -0.43 | -0.12 |
| EPS Diluted Continuous Ops | -0.90 | -0.81 | -0.77 | -0.42 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.90 | -0.81 | -0.69 | -0.43 | N/A |
| EBITDA(a) | $-48,116 | $-47,185 | $-32,593 | $-15,649 | $2,285 |